Arbutus Biopharma News - ABUS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Arbutus Biopharma Corporation ABUS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.08 3.6% 2.30 2.35 2.22 2.23 2.22 10:32:14
more quote information »

Recent News

Date Time Source Heading
11/06/201912:28EDGARQuarterly Report (10-q)
11/06/201907:35EDGARCurrent Report Filing (8-k)
11/06/201907:30GLOBEArbutus Reports Third Quarter 2019 Financial Results and..
11/05/201914:43EDGARStatement of Ownership (sc 13g)
10/30/201907:30GLOBEArbutus to Report Third Quarter 2019 Financial Results
10/03/201916:16EDGARCurrent Report Filing (8-k)
10/03/201916:05GLOBEArbutus Announces Decision to Discontinue Development..
9/26/201907:30GLOBEArbutus to Participate in Upcoming Investor Conferences
8/26/201916:15EDGARCurrent Report Filing (8-k)
8/20/201916:18EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:18EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:18EDGARInitial Statement of Beneficial Ownership (3)
8/20/201916:17EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:17EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:17EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:16EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:16EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201916:10EDGARCurrent Report Filing (8-k)
8/20/201916:05GLOBEArbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its..
8/09/201916:32EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/09/201916:06EDGARCurrent Report Filing (8-k)
8/06/201907:30GLOBEArbutus to Participate at Wedbush PacGrow Healthcare..
8/05/201912:30EDGARQuarterly Report (10-q)
8/05/201911:33EDGARCurrent Report Filing (8-k)
8/05/201907:30GLOBEArbutus Reports Second Quarter 2019 Financial Results and..
7/29/201907:30GLOBEArbutus to Report Second Quarter 2019 Financial Results
7/18/201916:06EDGARCurrent Report Filing (8-k)
7/17/201906:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/17/201906:01EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/16/201917:30EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/15/201916:05GLOBEArbutus Announces Preliminary Phase 1a/1b Clinical Trial..
7/12/201919:47EDGARStatement of Changes in Beneficial Ownership (4)
7/12/201916:58EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/12/201916:52EDGARStatement of Changes in Beneficial Ownership (4)
7/12/201916:47EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/12/201916:46EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/12/201916:40EDGARStatement of Changes in Beneficial Ownership (4)
7/12/201916:35EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/03/201916:29EDGARCurrent Report Filing (8-k)
7/02/201916:01GLOBEArbutus Sells Part of its ONPATTRO™ (patisiran) Royalty..
6/26/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
6/26/201916:19EDGARInitial Statement of Beneficial Ownership (3)
6/20/201907:30GLOBEArbutus receives regulatory clearance to initiate Phase..
6/18/201916:01EDGARCurrent Report Filing (8-k)
6/17/201907:30GLOBEArbutus Appoints William Collier as Next President & CEO and..
6/13/201908:30GLOBEArbutus to Participate at JMP Securities Life Sciences..
5/28/201916:54EDGARCurrent Report Filing (8-k)
5/20/201906:08EDGARCurrent Report Filing (8-k)
5/13/201908:30GLOBEArbutus to Present at Upcoming May 2019 Conferences
5/06/201917:31EDGARQuarterly Report (10-q)
See more news about this stock »


Your Recent History
NASDAQ
ABUS
Arbutus Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.